BioXcel Therapeutics
BTAI
$1.37
Share price
-2.84%
Change (1 day)
-93.19%
Change (1 year)
Categories
BioXcel Therapeutics (BTAI) - Total debt
Total debt on the balance sheet as of March 2024 : $0.10 B
According to BioXcel Therapeutics's latest financial reports the company's total debt is $0.10 B. A company’s total debt is the sum of all current and non-current debts.
BioXcel Therapeutics - Total debt on balance sheet (from 2017 to 2024)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $94.15 M | 8420.9% |
| 2021-12-31 | $1.1 M | -20.96% |
| 2020-12-31 | $1.39 M | 35.86% |
| 2019-12-31 | $1.02 M | |
| 2018-12-31 | $N/A | -100% |
| 2017-12-31 | $0.37 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $2.77 M | -97.28% | 🇺🇸 USA |